Background: Multiple initiatives aim to develop circulating tumour DNA (ctDNA) tests for early cancer detection in asymptomatic individuals. The few studies describing ctDNA-testing in both asymptomatic and symptomatic patients report lower ctDNA detection in the asymptomatic patients. Here, we explore if asymptomatic patients differ from symptomatic patients e.
View Article and Find Full Text PDFObjective: Circulating tumor DNA (ctDNA) is a candidate biomarker of cancer with practice-changing potential in the detection of both early and residual disease. Disease stage and tumor size affect the probability of ctDNA detection, whereas little is known about the influence of other tumor characteristics on ctDNA detection. This study investigates the impact of tumor cell whole-genome doubling (WGD) on the detection of ctDNA in plasma collected preoperatively from newly diagnosed colorectal cancer (CRC) patients.
View Article and Find Full Text PDFBackground: More than 50% of patients have a major complication after emergency gastrointestinal surgery. Intravenous (i.v.
View Article and Find Full Text PDFA 31-year-old pregnant woman was admitted and treated for diabetic ketoacidosis. As the patient deteriorated and the viability of the foetus was uncertain a CT scan was done which showed free fluid and air intraabdominally. Surgery was performed.
View Article and Find Full Text PDFWe present a case of a 60-year-old man with no previous history of Crohn's disease who presented with abdominal pain and vomiting. X-ray examination of the abdomen showed obstructive ileus and the patient underwent emergency surgery. The resected terminal ileum was stenosed with characteristic changes of Crohn's disease.
View Article and Find Full Text PDF